Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any atrioventricular septal defect in which the cause of the disease is a mutation in the GATA6 gene.
Features include always present findings: Hypoplastic left heart, Atrioventricular canal defect, and Muscular ventricular septal defect.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 2 | Hypoplastic left heart, Muscular ventricular septal defect |
GATA6 encodes GATA binding protein 6 (595 aa). Transcriptional activator. Regulates SEMA3C and PLXNA2. Involved in gene regulation specifically in the gastric epithelium. May regulate genes that protect epithelial cells from bacterial infection. Highest expression in Ovary (121.3 TPM) and Adrenal Gland (65.6 TPM).
Atrioventricular septal defect 5 is associated with mutations in the GATA6 gene on chromosome 18.
The GATA6 protein participates in GATA6-AS1 lncRNA, Expression of GATA6 in cardiogenesis, and Expression of GATA6 in definitive endoderm pathways.
GATA6 is classified as a druggable target (Clinically Actionable, Transcription Factor, and Transcription Factor Complex categories) with score 13.1.
Genetic testing for GATA6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for atrioventricular septal defect 5 has been reported in the published literature.
Phenotype severity distribution: 3 always present features.
No clinical trials have been registered for atrioventricular septal defect 5.
82 publications have been identified in PubMed for atrioventricular septal defect 5. Research spans Clinical Trial Publication (43%), Case Report / Case Series (22%), and Epidemiology / Natural History (21%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 35 | 43% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:39 PM UTC
Online Mendelian Inheritance in Man
1 |
Muscular ventricular septal defect |
Patient case studies
18 |
22% |
Disease patterns and progression | 17 | 21% |
Laboratory research | 6 | 7% |
New treatment approaches | 3 | 4% |
Research summaries | 2 | 2% |
Testing and diagnosis research | 1 | 1% |
Nasir M (2026). [PMID: 41851657](https://pubmed.ncbi.nlm.nih.gov/41851657/). *BMC Pediatr*. [Epidemiology / Natural History]
Hosoda R (2026). [PMID: 42112270](https://pubmed.ncbi.nlm.nih.gov/42112270/). *J Cardiol Cases*. [Case Report / Case Series]
Seed M (2026). [PMID: 42223939](https://pubmed.ncbi.nlm.nih.gov/42223939/). *JAMA Netw Open*. [Epidemiology / Natural History]
Islam MT (2026). [PMID: 41939622](https://pubmed.ncbi.nlm.nih.gov/41939622/). *Cureus*. [Epidemiology / Natural History]
Hansen S (2026). [PMID: 41880298](https://pubmed.ncbi.nlm.nih.gov/41880298/). *PLoS One*. [Clinical Trial Publication]
O'Connor M (2026). [PMID: 40208292](https://pubmed.ncbi.nlm.nih.gov/40208292/). *Pediatric cardiology*. [Clinical Trial Publication]
Deeb A (2026). [PMID: 42130552](https://pubmed.ncbi.nlm.nih.gov/42130552/). *Int J Surg Case Rep*. [Case Report / Case Series]
Hassaballa AS (2026). [PMID: 41971883](https://pubmed.ncbi.nlm.nih.gov/41971883/). *JTCVS Tech*. [Case Report / Case Series]
Zhang H (2026). [PMID: 42205793](https://pubmed.ncbi.nlm.nih.gov/42205793/). *Front Cardiovasc Med*. [Case Report / Case Series]
Suzuki E (2026). [PMID: 41761153](https://pubmed.ncbi.nlm.nih.gov/41761153/). *BMC Pediatr*. [Case Report / Case Series]